Skip to main content

Advertisement

Log in

Stress Dose Steroids: Myths and Perioperative Medicine

  • Surgery and Perioperative Care (CR MacKenzie and SM Goodman, Section Editors)
  • Published:
Current Rheumatology Reports Aims and scope Submit manuscript

Abstract

Perioperative medication management for patients with systemic autoimmune inflammatory diseases has focused on strategies to improve outcomes and mitigate risks. The emphasis has been to minimize the risk of infection associated with most antirheumatic medications, while attempting to avoid flares of disease precipitated by medication withdrawal. Management of glucocorticoids in the perioperative period has been based on an assumption that supraphysiologic increases in dose were always necessary to avoid hypotension and shock in glucocorticoid treated patients, and alternative strategies were rarely considered despite the known infectious, metabolic, and wound healing risks associated with glucocorticoid administration. This paper will review current recommendations for perioperative glucocorticoid administration for glucocorticoid treated patients with systemic inflammatory autoimmune diseases and discuss glucocorticoid physiology to analyze the basis for these recommendations and consider alternative perioperative management strategies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance

  1. Scanzello CR, Figgie MP, Nestor BJ, Goodman SM. Perioperative management of medications used in the treatment of rheumatoid arthritis. HSS J. 2006;2(2):141–7.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Goodman SM. Perioperative Care of the Orthopedic Patient with Connective Tissue Disease MacKenzie CR, Cornell CN and SG Memtsoudis. Peroperative Care of the Orthopedic Patient 2014;1014:113.

  3. Grennan DM, Gray J, Loudon J, Fear S. Methotrexate and early postoperative complications in patients with rheumatoid arthritis undergoing elective orthopaedic surgery. Ann Rheum Dis. 2001;60(3):214–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Bongartz T. Elective orthopedic surgery and perioperative DMARD management: many questions, fewer answers, and some opinions. J Rheumatol. 2007;34(4):653–5.

    PubMed  Google Scholar 

  5. van Vollenhoven RF, Petri M, Wallace DJ, Roth D, Molta CT, Hammer AE, et al. Cumulative corticosteroids over 52 weeks in patients with systemic lupus erythematosus: Pooled analyses from the phase III belimumab trials. Arthritis Rheumatol 2016. doi:10.1002/art.39682.

  6. Caplan L, Wolfe F, Russell AS, Michaud K. Corticosteroid use in rheumatoid arthritis: prevalence, predictors, correlates, and outcomes. J Rheumatol. 2007;34(4):696–705.

    PubMed  Google Scholar 

  7. Coursin DB, Wood KE. Corticosteroid supplementation for adrenal insufficiency. JAMA. 2002;287(2):236–40.

    Article  CAS  PubMed  Google Scholar 

  8. Prescott P. Disorders of the adrenal cortex. In: Lubin MF, Dodson TF, Winawer NH, editors. Medical management of the surgical patient. New York: Cambridge University Press; 2013.

  9. Chrousos GP. Stress and disorders of the stress system. Nat Rev Endocrinol. 2009;5(7):374–81.

    Article  CAS  PubMed  Google Scholar 

  10. Elenkov IJ, Chrousos GP. Stress system—organization, physiology and immunoregulation. Neuroimmunomodulation. 2006;13(5-6):257–67.

    Article  CAS  PubMed  Google Scholar 

  11. Marik PE, Varon J. Requirement of perioperative stress doses of corticosteroids: a systematic review of the literature. Arch Surg. 2008;143(12):1222–6.

    Article  CAS  PubMed  Google Scholar 

  12. Lamberts SW, Bruining HA, de Jong FH. Corticosteroid therapy in severe illness. N Engl J Med. 1997;337(18):1285–92.

    Article  CAS  PubMed  Google Scholar 

  13. Fraser CG, Preuss FS, BIGFORD WD. Adrenal atrophy and irreversible shock associated with cortisone therapy. J Am Med Assoc. 1952;149(17):1542–3.

    Article  CAS  PubMed  Google Scholar 

  14. Marik PE, Zaloga GP. Adrenal insufficiency in the critically ill: a new look at an old problem. Chest. 2002;122(5):1784–96.

    Article  PubMed  Google Scholar 

  15. Glowniak JV, Loriaux DL. A double-blind study of perioperative steroid requirements in secondary adrenal insufficiency. Surgery. 1997;121(2):123–9. A small (18 patients) but blinded, randomized trial of perioperative steroids demonstrating no benefit from such therapy.

    Article  CAS  PubMed  Google Scholar 

  16. Thomason JM, Girdler NM, Kendall-Taylor P, Wastell H, Weddel A, Seymour RA. An investigation into the need for supplementary steroids in organ transplant patients undergoing gingival surgery. A double-blind, split-mouth, cross-over study. J Clin Periodontol. 1999;26(9):577–82.

    Article  CAS  PubMed  Google Scholar 

  17. Yong SL, Marik P, Esposito M, Coulthard P. Supplemental perioperative steroids for surgical patients with adrenal insufficiency. Cochrane Database Syst Rev 2009; Oct 7;(4):CD005367. doi(4):CD005367.

  18. Jasani MK, Freeman PA, Boyle JA, Downie WW, Wright JH, Buchanan WW. Cardiovascular and plasma cortisol responses to surgery in corticosteroid-treated R. A. patients. Acta Rheumatol Scand. 1968;14(1):65–70. This cohort study also examines the postoperative biochemical and clinical consequences of the administration (or not) of perioperative steroids showing no benefit. This study is probably the most extensive investigation of this therapy extant.

    Article  CAS  PubMed  Google Scholar 

  19. Jasani MK, Boyle JA, Greig WR, Dalakos TG, Browning MC, Thompson A, et al. Corticosteroid-induced suppression of the hypothalamo-pituitary-adrenal axis: observations on patients given oral corticosteroids for rheumatoid arthritis. Q J Med. 1967;36(143):261–76.

    CAS  PubMed  Google Scholar 

  20. Dixon WG, Abrahamowicz M, Beauchamp ME, Ray DW, Bernatsky S, Suissa S, et al. Immediate and delayed impact of oral glucocorticoid therapy on risk of serious infection in older patients with rheumatoid arthritis: a nested case-control analysis. Ann Rheum Dis. 2012;71(7):1128–33.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Movahedi M, Beauchamp ME, Abrahamowicz M, Ray DW, Michaud K, Pedro S, et al. Risk of Incident Diabetes Associated with Dose and Duration of Oral Glucocorticoid Therapy in Patients with Rheumatoid Arthritis. Arthritis Rheumatol 2016;68(5):1089–98.

  22. Somayaji R, Barnabe C, Martin L. Risk factors for infection following total joint arthroplasty in rheumatoid arthritis. Open Rheumatol J. 2013;7:119–24.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Jung C, Inder WJ. Management of adrenal insufficiency during the stress of medical illness and surgery. Med J Aust. 2008;188(7):409–13.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to C. Ronald MacKenzie.

Ethics declarations

Conflicts of Interest

CRM and SMG declare that they have no conflicts of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

This article is part of the Topical Collection on Surgery and Perioperative Care

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

MacKenzie, C.R., Goodman, S.M. Stress Dose Steroids: Myths and Perioperative Medicine. Curr Rheumatol Rep 18, 47 (2016). https://doi.org/10.1007/s11926-016-0595-7

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s11926-016-0595-7

Keywords

Navigation